Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

Press Releases

All Releases
View Summary OPKO Health Reports 2017 Third Quarter Highlights and Financial Results
Nov 8, 2017
PDF 31.0 KB
View Summary OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform
Nov 7, 2017
PDF 14.7 KB
View Summary OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017
Nov 3, 2017
PDF 11.8 KB
View Summary OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy
Oct 26, 2017
PDF 17.1 KB
View Summary OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan
Oct 12, 2017
PDF 16.7 KB
View Summary OPKO's BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care
Sep 19, 2017
PDF 23.9 KB
View Summary OPKO's GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings
Sep 12, 2017
PDF 20.0 KB
View Summary OPKO Health to Present at Upcoming September Conferences
Aug 31, 2017
PDF 14.0 KB
View Summary OPKO Health Reports Second Quarter 2017 Business and Financial Results
Aug 8, 2017
PDF 32.1 KB
View Summary OPKO Health to Announce 2017 Second Quarter Financial Results on August 8, 2017
Aug 3, 2017
PDF 14.1 KB
View Summary OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD
Jun 22, 2017
PDF 110.8 KB
View Summary OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults
Jun 15, 2017
PDF 16.4 KB
View Summary OPKO'S GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing
Jun 7, 2017
PDF 20.5 KB
View Summary OPKO Health Provides Commercial Update for RAYALDEE
Jun 5, 2017
PDF 70.0 KB
View Summary OPKO Health's 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting
May 18, 2017
PDF 22.6 KB
View Summary OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting 
May 15, 2017
PDF 18.8 KB
View Summary CORRECTION -- OPKO Health Inc.
May 9, 2017
PDF 10.7 KB
View Summary OPKO Health Reports 2016 Financial and Operating Results
May 9, 2017
PDF 34.0 KB
View Summary OPKO Health to Announce 2017 First Quarter Financial Results on May 9, 2017
May 8, 2017
PDF 15.3 KB
View Summary OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder
Mar 22, 2017
PDF 17.4 KB
Showing 1-20 of 341 Page: 1 2 3 4 5 ... 18  Next 20

Email  Sign up for email alerts